(Q44021677)

29 November 2017

Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients (English)

1 reference

29 November 2017

1 reference

Protein 3a [SARS-Cov]

0 references

author name string

Xiaofen Zhong

1

1 reference

29 November 2017

Zufeng Guo

2

1 reference

29 November 2017

Huanghao Yang

3

1 reference

29 November 2017

Lisheng Peng

4

1 reference

29 November 2017

Yong Xie

5

1 reference

29 November 2017

Tin-Yau Wong

6

1 reference

29 November 2017

Sik-To Lai

7

1 reference

29 November 2017

Zhihong Guo

8

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Journal of General Virology

29 November 2017

1 reference

29 November 2017

87

1 reference

29 November 2017

Pt 2

1 reference

29 November 2017

369-373

1 reference

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

29 November 2017

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Antibody detection of SARS-CoV spike and nucleocapsid protein

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Effects of a SARS-associated coronavirus vaccine in monkeys.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

A candidate vaccine for severe acute respiratory syndrome

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

A novel coronavirus associated with severe acute respiratory syndrome

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Coronavirus as a possible cause of severe acute respiratory syndrome

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Identification of severe acute respiratory syndrome in Canada

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

The Coronavirus Membrane Glycoprotein

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

DNA vaccine of SARS-Cov S gene induces antibody response in mice.

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein

16 April 2021

1 reference

https://api.crossref.org/works/10.1099/VIR.0.81078-0

The Small-Membrane Protein

16 April 2021

0 references

Identifiers

DOI

10.1099/VIR.0.81078-0

1 reference

29 November 2017

1 reference